Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data
Human genetic variants inSLC16A11are associatedwith increased risk of type 2 diabetes (T2D). We pre-viously identified two distinct mechanisms throughwhich co-inherited T2D-risk coding and non-codingvariants disruptSLC16A11expression and activity,thus implicating reduced SLC16A11 function as thedise...
Main Author: | Lander, Eric S. (Author) |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology (Contributor) |
Format: | Article |
Language: | English |
Published: |
Elsevier BV,
2020-05-13T13:25:29Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data
by: Eitan Hoch, et al.
Published: (2019-10-01) -
Type 2 Diabetes Variants in the SLC16A11 Coding Region Are Not Loss-of-Function Mutations
by: Yongxu Zhao, et al.
Published: (2019-10-01) -
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms
by: Rusu, Victor, et al.
Published: (2018) -
Evidence of association with type 1 diabetes in the SLC11A1 gene region
by: Walker Neil M, et al.
Published: (2011-04-01) -
Lack of Association between SLC30A8 Variants and Type 2 Diabetes in Mexican American Families
by: Hemant Kulkarni, et al.
Published: (2016-01-01)